These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24870221)
21. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study. Sheehan R; Horsfall L; Strydom A; Osborn D; Walters K; Hassiotis A BMJ Open; 2017 Aug; 7(8):e017406. PubMed ID: 28775195 [TBL] [Abstract][Full Text] [Related]
24. Atypical neuroleptic malignant syndrome: A systematic review of case reports. Singhai K; Kuppili PP; Nebhinani N Gen Hosp Psychiatry; 2019; 60():12-19. PubMed ID: 31299470 [No Abstract] [Full Text] [Related]
25. [Clinical aspects, pathogenesis and treatment of neuroleptic malignant syndrome]. Sep-Kowalikowa B Psychiatr Pol; 1989; 23(1):44-53. PubMed ID: 2573100 [No Abstract] [Full Text] [Related]
26. Antipsychotic-Induced Neuroleptic Malignant Syndrome After Cardiac Surgery. Moll V; Ward CT; Zivot JB A A Case Rep; 2016 Jul; 7(1):5-8. PubMed ID: 27191714 [TBL] [Abstract][Full Text] [Related]
27. Neuroleptic malignant syndrome precipitated by promethazine and lorazepam. Duggal HS Aust N Z J Psychiatry; 2001 Apr; 35(2):250-1. PubMed ID: 11284912 [No Abstract] [Full Text] [Related]
28. Neuroleptic malignant syndrome: case report and review. Dykstra TJ; Menolasino MJ J Am Osteopath Assoc; 1997 Jun; 97(6):355-7. PubMed ID: 9232946 [TBL] [Abstract][Full Text] [Related]
29. Atypical neuroleptic malignant syndrome associated with risperidone treatment. Newman M; Adityanjee ; Jampala C Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841 [No Abstract] [Full Text] [Related]
30. Neuroleptic-induced movement disorders: an overview. Sachdev PS Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622 [No Abstract] [Full Text] [Related]
31. Neuroleptic malignant syndrome. Caroff SN; Mann SC; Lazarus A Arch Gen Psychiatry; 1987 Sep; 44(9):838-40. PubMed ID: 2888445 [No Abstract] [Full Text] [Related]
32. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report]. Terlikowska M; Marzański M Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087 [TBL] [Abstract][Full Text] [Related]
34. [Neuroleptic malignant syndrome in users of risperidone]. van Bemmel T; Westendorp RG Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646 [No Abstract] [Full Text] [Related]
35. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient]. Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639 [No Abstract] [Full Text] [Related]